Medicinal Chemicals & Botanical Products
Standard Industrial Classification: SIC 2833
Industry Insider Sentiment Analysis
The Medicinal Chemicals & Botanical Products sector (SIC 2833) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-04-11 20:21 | 2013-04-10 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $47.45 | 7,000 | $332,168 | 6,623,167 |
| 2013-03-16 01:49 | 2013-03-13 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $46.15 | 7,000 | $323,021 | 6,630,167 |
| 2013-03-16 01:49 | 2013-03-13 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $46.15 | 7,000 | $323,021 | 6,630,167 |
| 2013-02-14 21:51 | 2013-02-13 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $42.29 | 7,000 | $296,046 | 6,637,167 |
| 2013-02-14 21:51 | 2013-02-13 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $42.29 | 7,000 | $296,046 | 6,637,167 |
| 2013-02-13 19:30 | 2012-11-06 | BNLB | FITLIFE BRANDS, INC. | Vicis Capital, LLC | 10% owner | SELL | $0.01 | 25,213,638 | $148,760 | 0 |
| 2013-02-11 19:31 | 2013-02-08 | USNA | USANA HEALTH SCIENCES INC | Braun Doug | Officer | OPT+S | $41.11 | 3,923 | $161,273 | 0 |
| 2013-01-12 01:18 | 2013-01-09 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $37.60 | 7,000 | $263,196 | 6,644,167 |
| 2013-01-12 01:20 | 2013-01-09 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $37.60 | 7,000 | $263,196 | 6,644,167 |
| 2013-01-07 20:23 | 2012-12-28 | BNLB-OB | FITLIFE BRANDS, INC. | ADELMAN JASON T | 10% owner | BUY | $0.00 | 4,202,260 | $0 | 12,971,808 |
| 2013-01-04 03:21 | 2012-12-28 | BNLB-OB | FITLIFE BRANDS, INC. | ABRAMS MICHAEL S | Director, Officer | BUY | $0.00 | 1,050,565 | $0 | 1,795,565 |
| 2013-01-04 03:19 | 2012-12-28 | BNLB-OB | FITLIFE BRANDS, INC. | WILSON JOHN S | Director, Officer | BUY | $0.00 | 1,050,564 | $0 | 3,699,570 |
| 2012-12-27 02:32 | 2012-12-24 | MTEX | MANNATECH INC | JOBE LARRY A | Director | SELL | $6.36 | 1,000 | $6,364 | 14,000 |
| 2012-12-20 22:05 | 2012-12-19 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.62 | 15,000 | $9,300 | 3,275,057 |
| 2012-12-18 21:44 | 2012-12-12 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $43.15 | 7,000 | $302,019 | 6,651,167 |
| 2012-12-18 21:46 | 2012-12-12 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $43.15 | 7,000 | $302,019 | 6,651,167 |
| 2012-12-17 19:46 | 2012-12-14 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.63 | 28,900 | $18,207 | 3,260,057 |
| 2012-12-15 02:06 | 2012-12-12 | USNA | USANA HEALTH SCIENCES INC | MCCLAIN JERRY G | Director | SELL | $42.99 | 200 | $8,598 | 0 |
| 2012-12-14 03:47 | 2012-12-10 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $43.27 | 464,050 | $20,080,186 | 6,658,167 |
| 2012-12-14 03:47 | 2012-12-10 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $43.27 | 464,050 | $20,080,186 | 6,658,167 |
| 2012-12-11 21:17 | 2012-12-10 | USNA | USANA HEALTH SCIENCES INC | POELMAN RONALD S | Director | SELL | $43.17 | 5,000 | $215,846 | 0 |
| 2012-12-12 01:23 | 2012-12-07 | CYAN | CYANOTECH CORP | DAVIS MICHAEL A / | Director, 10% owner | BUY | $5.01 | 17,500 | $87,589 | 325,150 |
| 2012-12-04 00:24 | 2012-11-30 | USNA | USANA HEALTH SCIENCES INC | Bramble James | Officer | BUY | $40.80 | 500 | $20,400 | 500 |
| 2012-11-30 02:41 | 2012-11-27 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $44.03 | 60,343 | $2,656,890 | 7,122,217 |
| 2012-11-30 02:42 | 2012-11-27 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $44.03 | 60,343 | $2,656,890 | 7,122,217 |
| 2012-11-27 02:39 | 2012-11-21 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $43.83 | 67,562 | $2,961,074 | 7,182,560 |
| 2012-11-27 02:40 | 2012-11-21 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $43.83 | 67,562 | $2,961,074 | 7,182,560 |
| 2012-11-21 03:07 | 2012-11-20 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $43.90 | 7,918 | $347,600 | 7,250,122 |
| 2012-11-21 03:05 | 2012-11-16 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | OPT+S | $44.30 | 82,251 | $3,643,563 | 7,250,122 |
| 2012-11-20 01:28 | 2012-11-16 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.62 | 25,000 | $15,500 | 4,574,959 |
| 2012-11-16 20:17 | 2012-11-13 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $43.79 | 107,000 | $4,685,605 | 7,258,040 |
| 2012-11-16 20:18 | 2012-11-13 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $43.79 | 107,000 | $4,685,605 | 7,258,040 |
| 2012-11-14 04:15 | 2012-11-06 | BNLB-OB | FITLIFE BRANDS, INC. | WILSON JOHN S | Director, Officer | BUY | $0.00 | 1,399,352 | $0 | 2,649,006 |
| 2012-10-30 18:51 | 2012-10-26 | USNA | USANA HEALTH SCIENCES INC | FULLER GILBERT A | Director | SELL | $44.19 | 2,759 | $121,927 | 0 |
| 2012-10-11 18:21 | 2012-10-10 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $46.74 | 7,000 | $327,180 | 7,365,040 |
| 2012-10-11 18:24 | 2012-10-10 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | SELL | $46.74 | 7,000 | $327,180 | 7,365,040 |
| 2012-09-15 00:04 | 2012-09-12 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $46.86 | 7,000 | $328,020 | 7,372,040 |
| 2012-09-15 00:14 | 2012-09-14 | USNA | USANA HEALTH SCIENCES INC | AUCIAUX ROBERT | Director | OPT+S | $47.00 | 4,455 | $209,385 | 0 |
| 2012-09-15 00:05 | 2012-09-12 | USNA | USANA HEALTH SCIENCES INC | WENTZ MYRON W | Director | OPT+S | $46.33 | 102,204 | $4,735,009 | 7,372,040 |
| 2012-09-12 23:42 | 2012-09-11 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.77 | 7,500 | $5,775 | 3,231,157 |
| 2012-09-11 22:52 | 2012-08-30 | NPHC | Nutra Pharma Corporation | SARTORI BRUNO | SELL | $0.01 | 303,990 | $3,344 | 240,000 | |
| 2012-09-11 22:52 | 2012-04-23 | NPHC | Nutra Pharma Corporation | SARTORI BRUNO | BUY | $0.01 | 246,100 | $2,855 | 486,100 | |
| 2012-09-11 03:01 | 2012-09-06 | USNA | USANA HEALTH SCIENCES INC | WENTZ DAVE | Officer | OPT+S | $46.66 | 43,956 | $2,051,092 | 483,955 |
| 2012-09-05 23:03 | 2012-08-31 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.62 | 7,300 | $4,526 | 3,223,657 |
| 2012-09-05 21:09 | 2012-08-31 | CDXC-OB | Niagen Bioscience, Inc. | Brauser Michael | Director | BUY | $0.65 | 10,000 | $6,500 | 2,609,212 |
| 2012-09-05 18:39 | 2012-08-31 | USNA | USANA HEALTH SCIENCES INC | WENTZ DAVE | Officer | SELL | $45.45 | 20,000 | $909,000 | 483,955 |
| 2012-09-01 01:30 | 2012-08-29 | USNA | USANA HEALTH SCIENCES INC | Guest Kevin | Officer | OPT+S | $45.00 | 4,208 | $189,360 | 0 |
| 2012-08-16 18:23 | 2012-08-15 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.74 | 15,000 | $11,100 | 4,549,959 |
| 2012-08-14 19:39 | 2012-08-13 | CDXC-OB | Niagen Bioscience, Inc. | Honig Barry C | Director | BUY | $0.66 | 30,000 | $19,800 | 4,534,959 |
| 2012-08-11 01:32 | 2012-08-08 | USNA | USANA HEALTH SCIENCES INC | GULL HOLDINGS LTD | 10% owner | SELL | $44.21 | 7,000 | $309,470 | 7,379,040 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Medicinal Chemicals & Botanical Products sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2833) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Medicinal Chemicals & Botanical Products
Every transaction in the Medicinal Chemicals & Botanical Products industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.